BUKWANG PHARMACEUTICAL IND CO.,LTD

003000 KRX Pharmaceuticals Pharmaceuticals
KOSPI
₩3,970.00
-2.93%
Delayed · cached 15 min

Fair value analysis

003000
BUKWANG PHARMACEUTICAL IND CO.,LTD
Pharmaceuticals›Pharmaceuticals
₩3,970.00
Close used for this calculation
₩2,545.85Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
42/100
Profitability6/25
Returns2/25
Balance Sheet21/25
Efficiency13/25
Growth5/25
Average
Quality radar
42Prof.6/25Ret.2/25Eff.13/25B.Sht21/25Growth5/25

Consensus fair value

₩2,545.85
Above FV
▼ -35.9% against the close used
Model range ₩340.29 – ₩3,144.25
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₩340.29Fair value₩2,545.85Bull₩3,144.25
FairClose
52-week traded range
52W low ₩3,485.0052W high ₩9,330.00

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

BUKWANG PHARMACEUTICAL IND CO.,LTD closed at ₩3,970.00, 55.9% above the consensus fair value of ₩2,545.85 drawn from 8 valuation models.

Financial DNA score 42/100 — Average. P/E of 31.2x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
₩2,725.81
-31.3%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=8%, r=10%, tg=3%, n=10yr
Graham Number
₩3,144.25
-20.8%
√(22.5 × EPS × BVPS)
EPS=127.28, BVPS=3452.17 · outside Graham range (P/E 31.2, P/B 1.2) — asset-light, treat as a rough floor
P/E Fair Value
₩2,545.60
-35.9%
EPS × 20x (sector P/E)
EPS=127.28, Sector P/E=20x
EV/EBITDA
₩635.79
-84.0%
(EBITDA × 10x − Net Debt) ÷ Shares
EBITDA=14.16B
Dividend Discount (DDM)
₩1,670.38
-57.9%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=131.01, r=10%, g=2%
Book Value (P/B)
₩340.29
-91.4%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=3452.17, ROE=3.7%, g=3%, r=10%
Reverse DCF
₩3,970.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 13.1% | Historical: 0%
Margin of Safety
₩2,103.92
-47.0%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=2805.22, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.